Closed Loop Medicine

Focus: Closed Loop Medicine is a UK-based biotech specializing in digital-device combination therapeutics for cardiovascular and metabolic diseases. The company operates at pre-revenue or early-stage scale with a focus on real-world evidence and digital health integration.

Cardiovascular Metabolic Diseases

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Closed Loop Medicine

AI assessmentNot Hiring

No open roles listed right now. Follow Closed Loop Medicine to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

6 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Stage 2 Digital sleep diary app

Insomnia

N/A

Clinical Trials (1)

NCT05093426PERSONAL - Sleep In Breast Cancer

N/A

Help build intelligence for Closed Loop Medicine

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage opportunity in high-growth digital therapeutics and real-world evidence space, positioning you at the forefront of precision medicine convergence
Exposure to multiple therapeutic areas (cardiovascular, metabolic) with contemporary study designs including RWE-driven semaglutide personalization work
Cambridge location offers access to top-tier biotech ecosystem and talent pool in one of Europe's leading innovation hubs

Watch Out For

Zero active job openings at present signals potential hiring freeze, capacity constraints, or early-stage stage-gate approach to headcount
No disclosed funding, revenue, or financial data creates uncertainty about runway, burn rate, and sustainability through clinical and commercial milestones

Generated by Claude from Closed Loop Medicine's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Zestril

Hypertension

N/A

Clinical Trials (1)

NCT06745726OptiZ: Real World Evidence Study

N/A

WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults

Obesity & Overweight

N/A

Clinical Trials (1)

NCT07216651WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults

N/A

Zestril

Uncomplicated Hypertension

N/A

Clinical Trials (1)

NCT06372470Personalised Dose Optimisation of Zestril Supported by the Digital Blood Pressure Diary in a Primary Care Environment in England: Pragmatic Observational Pilot Study for Remote Hypertension Treatment

N/A

Amlodipine

Hypertension

PHASE_4

Clinical Trials (1)

NCT04559074Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension

Phase 4

Amlodipine

Hypertension

PHASE_4

Clinical Trials (1)

NCT06713785Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension